Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00754611 · ClinicalTrials.gov registry record

The Evolution and Management of Migraine Recurrence Beyond 24 Hours

A clinical trial, sponsored by Rowan University.

Completed
Registry status
100
Enrollment target

NCT00754611: Completed study, sponsored by Rowan University.

NCT00754611 is a clinical trial that has completed, run by Rowan University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00754611 has completed, sponsored by Rowan University.

COMPLETED
Registry status
100 participants
Enrollment target

Study Summary

What is the course of migraine headache recurrence, how is it managed, what characteristics are associated with it, and how does it influence patient satisfaction with treatment?

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2008-12
Est. Completion 2010-12
Rowan University

19 total trials

What the finished NCT00754611 record still lists

NCT00754611 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00754611 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00754611 about?

NCT00754611 is a clinical study titled "The Evolution and Management of Migraine Recurrence Beyond 24 Hours". What is the course of migraine headache recurrence, how is it managed, what characteristics are associated with it, and how does it influence patient satisfaction with treatment?

What is the current status of trial NCT00754611?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2008-12. Estimated completion is 2010-12.

Who is sponsoring clinical trial NCT00754611?

This trial is sponsored by Rowan University, which has 19 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00754611, the US trial registry maintained by the National Library of Medicine. NCT00754611 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.